Isoniazid is a first-line drug for tuberculosis (TB) but is not used for asthma treatment.
Asthma is managed using inhaled corticosteroids (budesonide), mast cell stabilizers (cromolyn sodium), and leukotriene receptor antagonists (zafirlukast).
TB and asthma affect the lungs differently, requiring distinct therapies.